Ignite Creation Date:
2024-05-06 @ 10:50 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03364348
Status:
COMPLETED
Last Update Posted:
2022-10-19
First Post:
2017-11-10
Brief Title:
4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer
Sponsor:
George W Sledge Jr
Organization:
Stanford University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Breast Cancer |
| HER2 Positive Breast Carcinoma |
| Recurrent Breast Carcinoma |
| Stage III Breast Cancer |
| Stage IIIA Breast Cancer |
| Stage IIIB Breast Cancer |
| Stage IIIC Breast Cancer |
Keywords: